Human breast tumours are diverse in their natural history and in their responsiveness to treatments 1 . Variation in transcriptional programs accounts for much of the biological diversity of human cells and tumours. In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome. Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals, using complementary DNA microarrays representing 8,102 human genes. These patterns provided a distinctive molecular portrait of each tumour. Twenty of the tumours were sampled twice, before and after a 16-week course of doxorubicin chemotherapy, and two tumours were paired with a lymph node metastasis from the same patient. Gene expression patterns in two tumour samples from the same individual were almost always more similar to each other than either was to any other sample. Sets of co-expressed genes were identi®ed for which variation in messenger RNA levels could be related to speci®c features of physiological variation. The tumours could be classi®ed into subtypes distinguished by pervasive differences in their gene expression patterns.
We proposed that the phenotypic diversity of breast tumours might be accompanied by a corresponding diversity in gene expression patterns that we could capture using cDNA microarrays. Systematic investigation of gene expression patterns in human breast tumours might then provide the basis for an improved molecular taxonomy of breast cancers. We analysed gene expression patterns in grossly dissected normal or malignant human breast tissues from 42 individuals (36 in®ltrating ductal carcinomas, 2 lobular carcinomas, 1 ductal carcinoma in situ, 1 ®broadenoma and 3 normal breast samples). Fluorescently labelled (Cy5) cDNA was prepared from mRNA from each experimental sample. We prepared cDNA, labelled using a second distinguishable¯uorescent nucleotide (Cy3), from a pool of mRNAs isolated from 11 different cultured cell lines (see Supplementary Information Table 1 ); this common`reference' sample provided an internal standard against which the gene expression of each experimental sample was compared 2, 3 .
Twenty of the forty breast tumours examined were sampled twice, as part of a larger study on locally advanced breast cancers (T 3 /T 4 and/or N 2 tumours; see ref. 4) . After an open surgical biopsy to obtain the`before' sample, each of these patients was treated with doxorubicin for an average of 16 weeks (range 12±23), followed by resection of the remaining tumour. In addition, primary tumours from two patients were also paired with a lymph node metastasis from the same patient. To help interpret the variation in expression patterns seen in the tumour samples, we also characterized 17 cultured cell lines (with one cell line cultured under three different conditions), which provided models for many of the cell types encountered in these tissue samples. In total, we analysed 84 cDNA microarray experiments (see Supplementary Information, Table 2 ; the primary data tables can be obtained at http://genomewww.stanford.edu/molecularportraits/).
A hierarchical clustering method was used to group genes on the basis of similarity in the pattern with which their expression varied over all samples 5 . The same clustering method was used to group the experimental samples (cell lines and tissues separately) on the basis of similarity in their patterns of expression. We focus ®rst on a set of 1,753 genes (about 22% of the 8,102 genes analysed), whose transcripts varied in abundance by at least fourfold from their median abundance in this sample set in at least three of the samples ( Fig. 1 ; see Supplementary Information Fig. 4 for the complete cluster diagram).
Three striking features of the gene expression patterns of these tumours are evident in Fig. 1 . First, the tumours show great variation in their patterns of gene expression. Second, this variation is multidimensional; that is, many different sets of genes show mainly independent patterns of variation. Third, these patterns have a pervasive order re¯ecting relationships among the genes, relationships among the tumours and connections between speci®c genes and speci®c tumours.
The hierarchical clustering algorithm organizes the experimental samples only on the basis of overall similarity in their gene expression patterns; these relationships are summarized in a dendrogram ( Fig. 1a) , in which the pattern and length of the branches re¯ects the relatedness of the samples 5 . Fifteen of the twenty before and after doxorubicin pairs (red dendrogram branches), and both primary tumour/lymph node metastasis pairs (light blue branches) were clustered together on terminal branches in the dendrogram; that is, despite an interval of 16 weeks, independent surgical procedures and cytotoxic chemotherapy, independent samples taken from the same tumour were in most cases recognizably more similar to each other than either was to any of the other samples. In three instances (Norway 47, 61 and 101), the`after' chemotherapy specimens clustered in a branch of the dendrogram that also contained the three normal breast samples; we know from the clinical data that these tumours were 3 of the 20 tumours that were classi®ed as doxorubicin`responders' (data not shown). An analysis of the relationship between gene expression and correlations with clinical data will be reported elsewhere (T.S. et al., manuscript in preparation).
The`molecular portraits' revealed in the patterns of gene expression not only uncovered similarities and differences among the tumours, but in many cases pointed to a biological interpretation. Variation in growth rate, in the activity of speci®c signalling pathways, and in the cellular composition of the tumours were all re¯ected in the corresponding variation in the expression of speci®c subsets of genes. The largest distinct cluster of genes within the 1,753-gene cluster diagram was the`proliferation cluster' (Supplementary Information Fig. 5 ), which is a group of genes whose levels of expression correlate with cellular proliferation rates 3, 6 . Expression of this cluster of genes varied widely among the tumour samples, and was generally well correlated with the mitotic index. As one might expect, this cluster also included the genes encoding two widely used immunohistochemical markers of cell proliferation (Ki-67 and PCNA).
Several groups of co-expressed genes provided views of the activities of speci®c signalling and/or regulatory systems. A large cluster of genes regulated by the interferon pathway (including STAT1) showed substantial variation in expression among the tumours, as was previously observed in a smaller set of breast 6 . Variation in expression of the oestrogen receptor-a gene (ER) correlated well with the direct clinical measurement of the ER protein levels in the tumours (Supplementary Information Table 3 ; concordance in 36/38 samples), and paralleled variation in the expression of a larger group of genes that included three other transcription factors (GATA-binding protein 3 (refs 7, 8), X-box binding protein 1 and hepatocyte nuclear factor 3a). HER2/neu, also known as Erb-B2, is overexpressed in 20±30% of all breast tumours, usually associated with DNA ampli®cation of the Erb-B2 locus 9, 10 . Notably, most of the other genes contained within the Figure 3 Cluster analysis using the`intrinsic' gene subset. Two large branches were apparent in the dendrogram, and within these large branches were smaller branches for which common biological themes could be inferred. Branches are coloured accordingly: basal-like, orange; Erb-B2+, pink; normal-breast-like, light green; and luminal epithelial/ER+, dark blue. a, Experimental sample associated cluster dendrogram. Small black bars beneath the dendrogram identify the 17 pairs that were matched by this hierarchical clustering; larger green bars identify the positions of the three pairs that were not matched by the clustering. b, Scaled-down representation of the intrinsic cluster diagram (see Supplementary  Information Fig. 6 ). c, Luminal epithelial/ER gene cluster. d, Erb-B2 overexpression cluster. e, Basal epithelial cell associated cluster containing keratins 5 and 17. f, A second basal epithelial-cell-enriched gene cluster.
Erb-B2 cluster were located in this same region of chromosome 17, and were also ampli®ed on the genomic DNA level (ref. 10; and J.R.P., unpublished data). Finally, a cluster of genes that included c-Fos and JunB co-varied in expression among the tumour specimens. We have found that this subset of genes is characteristically induced by prolonged handling of the samples after surgical resection (M.v.d.R. and C.M.P., unpublished data).
Human breast tumours are histologically complex tissues, containing a variety of cell types in addition to the carcinoma cells 11 . In analysing the gene expression patterns in solid human tumours, we used two lines of reasoning to infer the lineage of the cells that accounted for the apparently cell-type-speci®c expression of particular clustered groups of genes. First, such clusters included genes whose expression patterns have been previously characterized and that consistently pointed to a speci®c cell type. Second, these inferences were often corroborated by comparable expression of the same cluster in one or more of the cultured cell lines. Thus, eight independent clusters of genes appeared to re¯ect variation in speci®c cell types present within the tumours (Fig. 1c±j) .
(1) Endothelial cells: a cluster of genes characteristically expressed by endothelial cells, including CD34, CD31 and von Willebrand factor were also strongly expressed in the two endothelial cell lines HUVEC and HMVEC (Fig. 1c ). (2) Stromal cells: a previously characterized cluster of genes that included several isoforms of collagen showed signi®cant variation in expression among samples ( Fig. 1d) 3, 6 . (3) Adipose-enriched/normal breast cells: a cluster of genes including fatty-acid binding protein 4 and PPARg may represent the presence of adipose cells (Fig. 1g ). (4) B lymphocytes: variation in expression of a cluster of genes that were highly expressed in the multiple myeloma-derived cell line RPMI-8226, including many immunoglobulin genes, appears to represent variable B-cell in®ltration (Fig. 1f ). (5) T lymphocytes: a cluster of genes including CD3d and two subunits of the T-cell receptor were highly expressed in the T-cell leukaemia-derived cell line MOLT-4 and probably indicate T-cell in®ltrates (Fig. 1i ). (6) Macrophages: a cluster of genes that appeared to be markers of macrophage/ monocytes included CD68, acid phosphatase 5, chitinase and lysozyme (Fig. 1h) .
Two distinct types of epithelial cell are found in the human mammary gland: basal (and/or myoepithelial) cells and luminal epithelial cells 11, 12 . These two cell types are conveniently distinguished immunohistochemically; basal epithelial cells can be stained with antibodies to keratin 5/6 ( Fig. 2a ), whereas luminal epithelial cells stain with antibodies against keratins 8/18 (Fig. 2b) . Many genes were expressed by one of these two cell lineages, but not by the other (Fig. 1e and j) . The gene expression cluster characteristic of basal epithelial cells included keratin 5, keratin 17, integrin-b4 and laminin (Fig. 1e) 11 . The gene expression cluster characteristic of the luminal cells was anchored by the previously noted cluster of transcription factors that included ER (Fig. 1j) .
One goal of this study was to develop a system for classifying tumours on the basis of their gene expression patterns. The subset of genes shown in Fig. 1 was not necessarily optimal for this purpose, as the choice of genes whose expression levels provided the basis for the ordering of the tumour samples determined which phenotypic relationships among the tumours were re¯ected in the clustering patterns. We therefore selected an alternative subset of genes to use as the basis for a new clustering analysis.
The rationale behind this alternative gene subset was that speci®c features of a gene expression pattern that are to be used to classify tumours should be similar in any sample taken from the same tumour, and they should vary among different tumours. The 22 paired samples provided a unique opportunity for a deliberate and systematic search for such genes. From the genes whose expression was well measured in the 65 tissue samples, we selected a subset of 496 genes (termed the`intrinsic' gene subset) that consisted of genes with signi®cantly greater variation in expression between different tumours than between paired samples from the same tumour (see Supplementary Information). When variation in expression of this set of genes was used to order the tissue samples ( Fig. 3; and Supplementary Information Fig. 6 ), 17 of the 20`before and after' doxorubicin pairs were grouped together as were both of the tumour/ lymph node metastasis pairs. Qualitatively similar sample clustering patterns were obtained when a second gene subset that focused on genes expressed by epithelial cell types, and which had only 25% overlap with the intrinsic gene subset, was used (data not shown).
The division of the tissue samples into two subgroups was a striking feature of the intrinsic gene subset cluster analysis (Fig. 3a) . As a test of the robustness of this division, we applied the`weighted voting' method 13 . This algorithm recapitulated the sorting of the tissue samples between these two subgroups for all but 1 of the 65 samples (data not shown). It is important to note, however, that there is extensive residual variation in expression patterns within each of these two broad subgroups. Indeed, many of the ®ner subdivisions probably have important biological properties (see below).
The two dendrogram branches in Fig. 3 largely separate the tumour samples into those that were clinically described as ER positive (blue) and those that were ER negative (other colours). The tumours in the ER+ group were characterized by the relatively high expression of many genes expressed by breast luminal cells (Fig. 3c ). This connection was further corroborated using immunohistochemical analysis and antibodies against the luminal cell keratins 8/18 (Fig. 2c ). With one exception, none of the tumours in this group expressed Erb-B2 at high levels (Fig. 3d) .
Many of the genes characteristic of breast basal epithelial cells were also highly expressed in a group of six clustered tumours (Fig. 3e) . To corroborate the`basal-like' characteristics of these tumours, we carried out immunohistochemistry using antibodies against the breast basal cell keratins 5/6 and 17. All six of these tumours showed staining for either keratins 5/6 or 17 or both (Fig. 2d) . Notably, these six tumours also failed to express ER and most of the other genes that were usually co-expressed with it ( Fig. 3c ). Breast tumours that stain positive for basal keratins have been described 14±16 , and basal keratins may account for 3±15% of all breast tumours 15,17±19 ; in this study, the incidence was 15% (6/40).
As mentioned above, overexpression of the Erb-B2 oncogene was associated with the high expression of a speci®c subset of genes. We identi®ed a cluster of tumours that was partially characterized by the high level of expression of this subset of genes (Fig. 3d ). These tumours also showed low levels of expression of ER 20, 21 and of almost all of the other genes associated with ER expressionÐa trait they share with the basal-like tumours.
Several tumour samples and the single ®broadenoma tested (Fig. 3, light green) , were clustered with a group of samples that also contained the three normal breast specimens (Fig. 3a) . Thè normal breast' gene expression pattern is typi®ed by the high expression of genes characteristic of basal epithelial cells and adipose cells, and the low expression of genes characteristic of luminal epithelial cells.
The number of clearly different molecular phenotypes observed among the breast tumours suggests that we are far from having a complete picture of the diversity of breast tumours. When hundreds (instead of tens) of breast tumours have been characterized, a more de®ned tumour classi®cation is likely, and statistically signi®cant relationships with clinical parameters should be uncovered. We were, however, able to identify four groups of samples that might be related to different molecular features of mammary epithelial biology (that is, ER+/luminal-like, basal-like, Erb-B2+ and normal breast). An important implication of this study is that the clinical designation of`oestrogen receptor negative' breast carcinoma encompasses at least two biologically distinct subtypes of tumours (basal-like and ErB-B2 positive), which may need to be treated as distinct diseases.
A striking conclusion from these data concerns the stability, homogeneity and uniqueness of the`molecular portraits' provided by the quantitative analysis of gene expression patterns. We infer that these portraits faithfully represent the`tumour' itself, and not merely the particular tumour`sample', because we could recognize the distinctive expression pattern of a tumour in independent samples. The ®nding that a metastasis and primary tumour were as similar in their overall pattern of gene expression as were repeated samplings of the same primary tumour, suggests that the molecular program of a primary tumour may generally be retained in its metastases. Finally, we have explicitly discussed only a tiny fraction of the genes whose expression patterns varied among these tumours. Attention to the thousands of individual genes that de®ne the molecular portraits of each tumour, and learning to interpret their patterns of variation, will undoubtedly lead to a deeper and more complete understanding of breast cancers.
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Methods
Most of the techniques used in this work have been described elsewhere 2, 3, 22, 23 , and detailed protocols are available at hhttp://cmgm.Stanford.EDU/pbrown/i. The methods and protocols are also included in the Supplementary Information, and the primary data tables can be obtained at hhttp://genome-www.stanford.edu/molecularportraits/i.
